154 related articles for article (PubMed ID: 27611858)
1. Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc-Α2-Glycoprotein Levels in Patients with Type 2 Diabetes.
Liao X; Wang X; Li H; Li L; Zhang G; Yang M; Yuan L; Liu H; Yang G; Gao L
Sci Rep; 2016 Sep; 6():32887. PubMed ID: 27611858
[TBL] [Abstract][Full Text] [Related]
2. Effects of sitagliptin on circulating zinc-α2-glycoprotein levels in newly diagnosed type 2 diabetes patients: a randomized trial.
Tian M; Liang Z; Liu R; Li K; Tan X; Luo Y; Yang M; Gu HF; Liu H; Li L; Yang G
Eur J Endocrinol; 2016 Feb; 174(2):147-55. PubMed ID: 26546612
[TBL] [Abstract][Full Text] [Related]
3. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
[TBL] [Abstract][Full Text] [Related]
4. Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin.
Lei L; Li K; Li L; Fang X; Zhou T; Zhang C; Luo Y; Liu H; Li X; Zheng H; Zhang L; Yang G; Gao L
Nutr Metab (Lond); 2017; 14():53. PubMed ID: 28814962
[TBL] [Abstract][Full Text] [Related]
5. Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.
Yang M; Liu R; Li S; Luo Y; Zhang Y; Zhang L; Liu D; Wang Y; Xiong Z; Boden G; Chen S; Li L; Yang G
Diabetes Care; 2013 May; 36(5):1074-82. PubMed ID: 23275352
[TBL] [Abstract][Full Text] [Related]
6. The natural logarithm of zinc-α2-glycoprotein/HOMA-IR is a better predictor of insulin sensitivity than the product of triglycerides and glucose and the other lipid ratios.
Qu C; Zhou X; Yang G; Li L; Liu H; Liang Z
Cytokine; 2016 Mar; 79():96-102. PubMed ID: 26797477
[TBL] [Abstract][Full Text] [Related]
7. Zinc-α2-Glycoprotein Modulates AKT-Dependent Insulin Signaling in Human Adipocytes by Activation of the PP2A Phosphatase.
Ceperuelo-Mallafré V; Ejarque M; Duran X; Pachón G; Vázquez-Carballo A; Roche K; Núñez-Roa C; Garrido-Sánchez L; Tinahones FJ; Vendrell J; Fernández-Veledo S
PLoS One; 2015; 10(6):e0129644. PubMed ID: 26068931
[TBL] [Abstract][Full Text] [Related]
8. Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat.
Ceperuelo-Mallafré V; Näf S; Escoté X; Caubet E; Gomez JM; Miranda M; Chacon MR; Gonzalez-Clemente JM; Gallart L; Gutierrez C; Vendrell J
J Clin Endocrinol Metab; 2009 Dec; 94(12):5062-9. PubMed ID: 19846741
[TBL] [Abstract][Full Text] [Related]
9. Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs.
Ceperuelo-Mallafré V; Escoté X; Viladés C; Peraire J; Domingo P; Solano E; Sirvent JJ; Pastor R; Tinahones F; Leal M; Richart C; Vendrell J; Vidal F; ; Alba V; Aguilar A; Auguet T; Chacón MR; López-Dupla M; Megia A; Miranda M; Olona M; Saurí A; Vargas M; Velasco I; Veloso S; Fontanet A; Gutiérrez M; Mateo G; Muñoz J; Sambeat MA
HIV Med; 2012 May; 13(5):297-303. PubMed ID: 22256965
[TBL] [Abstract][Full Text] [Related]
10. Correlation analysis of IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus complicated with hypothyroidism.
He S; He Y; Jin F; Liu Y
Medicine (Baltimore); 2021 Apr; 100(15):e25432. PubMed ID: 33847643
[TBL] [Abstract][Full Text] [Related]
11. Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data.
Kurosaki E; Ogasawara H
Pharmacol Ther; 2013 Jul; 139(1):51-9. PubMed ID: 23563279
[TBL] [Abstract][Full Text] [Related]
12. Promising cardiovascular and blood pressure effects of the SGLT2 inhibitors: a new class of antidiabetic drugs.
Chrysant SG
Drugs Today (Barc); 2017 Mar; 53(3):191-202. PubMed ID: 28447076
[TBL] [Abstract][Full Text] [Related]
13. Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus.
Raskin P
Diabetes Metab Res Rev; 2013 Jul; 29(5):347-56. PubMed ID: 23463735
[TBL] [Abstract][Full Text] [Related]
14. Zinc-finger BED domain-containing 3 (Zbed3) is a novel secreted protein associated with insulin resistance in humans.
Jia Y; Yuan L; Hu W; Luo Y; Suo L; Yang M; Chen S; Wang Y; Liu H; Yang G; Li L
J Intern Med; 2014 May; 275(5):522-33. PubMed ID: 24283382
[TBL] [Abstract][Full Text] [Related]
15. The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM).
Basile JN
J Diabetes Complications; 2013; 27(3):280-6. PubMed ID: 23375850
[TBL] [Abstract][Full Text] [Related]
16. Plasma zinc α2-glycoprotein levels are elevated in smokers and correlated with metabolic syndrome.
Tsai JS; Chen SC; Huang KC; Lue BH; Lee LT; Chiu TY; Chen CY; Guo FR; Chuang LM
Eur J Clin Invest; 2015 May; 45(5):452-9. PubMed ID: 25708842
[TBL] [Abstract][Full Text] [Related]
17. Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes.
Li K; Xu X; Hu W; Li M; Yang M; Wang Y; Luo Y; Zhang X; Liu H; Li L; Yang G
Acta Diabetol; 2014 Dec; 51(6):981-90. PubMed ID: 25240528
[TBL] [Abstract][Full Text] [Related]
18. SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus.
Misra M
J Pharm Pharmacol; 2013 Mar; 65(3):317-27. PubMed ID: 23356840
[TBL] [Abstract][Full Text] [Related]
19. Sodium glucose co-transporter 2 (SGLT2) inhibitors: new among antidiabetic drugs.
Opie LH
Cardiovasc Drugs Ther; 2014 Aug; 28(4):331-4. PubMed ID: 24825435
[TBL] [Abstract][Full Text] [Related]
20. BI-10773, a sodium-glucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus.
Aires I; Calado J
Curr Opin Investig Drugs; 2010 Oct; 11(10):1182-90. PubMed ID: 20872321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
